SCYNEXIS (SCYX) Stock: Buy, Sell, or Hold?
$3.33
-0.08 (-2.49%)
▼
5d:
+0.91%
30d:
-15.91%
90d:
-35.71%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (87%)
Quality Score
48/100
Position
OVERSOLD
30-Day Fair Range
$3.48 – $4.29
Position: OVERSOLD
Forward P/E & Valuation
-2.0x
CHEAP
vs 1.5x historical avg
Wall Street Target
$32.67
+881.0% upside
Options IV & Volume
17th pct IV
HIGH volume confirmation
Support / Resistance
$3.28 / $4.00
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: SCYX shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When SCYX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SCYX is currently trading at $3.33, which is considered oversold relative to its 30-day fair value range of $3.48 to $4.29. From a valuation perspective, the stock is trading at a discount (Forward PE: -2.0) compared to its historical average (1.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SCYX is in a downtrend. The price is currently testing key support at $3.28. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (17th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $32.67 (+881.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SCYX is in a downtrend. The price is currently testing key support at $3.28. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (17th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $32.67 (+881.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.48 -
$4.29
Company Quality Score
48/100
(HOLD)
Options IV Signal
17th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
87.3%
Trading Range & Key Levels
30-Day Trading Range
$3.48 -
$4.29
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.74
(22.4%)
Support Level
$3.28
Resistance Level
$4.00
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 17th percentile)
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 881.0% below Wall St target ($32.67)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.02
Wall Street Target
$32.67
(+881.0%)
Revenue Growth (YoY)
-82.8%
Profit Margin
-53.3%
PE vs Historical
-2.0 vs 1.5
CHEAP
Share SCYX Analysis
Share this live SCYX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SCYX)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment dominates $SCYX on StockTwits with one user expressing frustration towards the management team and calling for their removal. No new news articles were available.
Key Retail Themes:
management incompetence
bearish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 10:17 PM ET
Data refreshes hourly during market hours. Next update: 11:17 PM
Data refreshes hourly during market hours. Next update: 11:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCYX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 41 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 60 BUY |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 36 SELL |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SCYX Research Pages
